MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.
Also called NCT02678923
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 126 participants
- Registry
-
NCT02678923 -
2015-000826-13
-
- Other papers using this trial's data
- Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Canada, Czechia, Hungary, Netherlands, Poland
- Registry status
- Completed
Technical summary
Registry record NCT02678923. Randomized; triple masking; primary purpose treatment. Start 2015-12-03 (actual); primary completion 2016-10-26 (actual). Results posted on 2017-07-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial
- Acronym
- PILOT
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- MDCO-216
- Intervention (Drug)
- Placebo
- Lead sponsor
- The Medicines Company
- Collaborator
- The Cleveland Clinic
Record details
- Record id
cardio:ct-nct02678923- Content hash
d0b27707cbd886f0c17628d9754ab79be0a504aacc9d88097df373f903a305e9